BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 3016157)

  • 1. Structure-activity relationships among alpha-(N)-heterocyclic acyl thiosemicarbazones and related compounds as inhibitors of herpes simplex virus type 1-specified ribonucleoside diphosphate reductase.
    Turk SR; Shipman C; Drach JC
    J Gen Virol; 1986 Aug; 67 ( Pt 8)():1625-32. PubMed ID: 3016157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective inhibition of herpes simplex virus ribonucleoside diphosphate reductase by derivatives of 2-acetylpyridine thiosemicarbazone.
    Turk SR; Shipman C; Drach JC
    Biochem Pharmacol; 1986 May; 35(9):1539-45. PubMed ID: 3011019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A quantitative analysis of steric and hydrophobic effects in ribonucleoside diphosphate reductase inhibition by thiosemicarbazones.
    Gupta SP; Prabhakar YS; Bindal MC; Handa A
    Arzneimittelforschung; 1984; 34(2):147-50. PubMed ID: 6372802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thiosemicarbazones of 2-acetylpyridine, 2-acetylquinoline, 1-acetylisoquinoline, and related compounds as inhibitors of herpes simplex virus in vitro and in a cutaneous herpes guinea pig model.
    Shipman C; Smith SH; Drach JC; Klayman DL
    Antiviral Res; 1986 Jul; 6(4):197-222. PubMed ID: 3017201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological activity of 3- and 5-amino derivatives of pyridine-2-carboxaldehyde thiosemicarbazone.
    Liu MC; Lin TS; Cory JG; Cory AH; Sartorelli AC
    J Med Chem; 1996 Jun; 39(13):2586-93. PubMed ID: 8691457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentiation of antiherpetic activity of acyclovir by ribonucleotide reductase inhibition.
    Spector T; Averett DR; Nelson DJ; Lambe CU; Morrison RW; St Clair MH; Furman PA
    Proc Natl Acad Sci U S A; 1985 Jun; 82(12):4254-7. PubMed ID: 2987969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ribonucleotide reductase of herpes simplex virus type 2 resembles that of herpes simplex virus type 1.
    Averett DR; Furman PA; Spector T
    J Virol; 1984 Dec; 52(3):981-3. PubMed ID: 6092726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha-(N)-heterocyclic carboxaldehyde thiosemicarbazone inhibitors of ribonucleoside diphosphate reductase.
    Booth BA; Agrawal KC; Moore EC; Sartorelli AC
    Cancer Res; 1974 Jun; 34(6):1308-14. PubMed ID: 4363653
    [No Abstract]   [Full Text] [Related]  

  • 9. Influence of vehicle on topical efficacy of 2-acetylpyridine thiosemicarbazone and related derivatives on in vivo type 2 herpes simplex virus infections.
    Sidwell RW; Huffman JH; Schafer TW; Shipman C
    Chemotherapy; 1990; 36(1):58-69. PubMed ID: 2155092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Schedule-dependency assessments of ribonucleoside diphosphate reductase inhibitors when used in combination with platinum compounds plus cyclophosphamide in the treatment of advanced L1210 leukemia.
    Gale GR; Atkins LM; Meischen SJ; Schwartz P
    Cancer Treat Rep; 1979 Mar; 63(3):449-56. PubMed ID: 427825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-function relationships for a new series of pyridine-2-carboxaldehyde thiosemicarbazones on ribonucleotide reductase activity and tumor cell growth in culture and in vivo.
    Cory JG; Cory AH; Rappa G; Lorico A; Liu MC; Lin TS; Sartorelli AC
    Adv Enzyme Regul; 1995; 35():55-68. PubMed ID: 7572354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific inhibition of the subunits of ribonucleotide reductase as a new approach to combination chemotherapy.
    Cory JG; Sato A; Lasater L
    Adv Enzyme Regul; 1980; 19():139-50. PubMed ID: 7039256
    [No Abstract]   [Full Text] [Related]  

  • 13. alpha-N-heterocyclic thiosemicarbazone derivatives as potential antitumor agents: a structure-activity relationships approach.
    Matesanz AI; Souza P
    Mini Rev Med Chem; 2009 Oct; 9(12):1389-96. PubMed ID: 19929812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on antipeptic ulcer agents: the quantitative structure-activity relationship analysis of heterocyclic aldehyde N4-substituted phenyl (thio) semicarbazones.
    Guo Z; Yang G; Chu F; Zhang S; Yu Y
    Chin Med Sci J; 1991 Jun; 6(2):71-3. PubMed ID: 1804380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 4-methyl-5-amino-1-formylisoquinoline thiosemicarbazone, a second-generation antineoplastic agent of the alpha-(N)-heterocyclic carboxaldehyde thiosemicarbazone series.
    Agrawal KC; Schenkman JB; Denk H; Mooney PD; Moore EC; Wodinsky I; Sartorelli AC
    Cancer Res; 1977 Jun; 37(6):1692-6. PubMed ID: 870183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2-Acetylpyridine thiocarbonohydrazones. Potent inactivators of herpes simplex virus ribonucleotide reductase.
    Blumenkopf TA; Harrington JA; Koble CS; Bankston DD; Morrison RW; Bigham EC; Styles VL; Spector T
    J Med Chem; 1992 Jun; 35(12):2306-14. PubMed ID: 1319497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitors of ribonucleotide reductase. Comparative effects of amino- and hydroxy-substituted pyridine-2-carboxaldehyde thiosemicarbazones.
    Cory JG; Cory AH; Rappa G; Lorico A; Liu MC; Lin TS; Sartorelli AC
    Biochem Pharmacol; 1994 Jul; 48(2):335-44. PubMed ID: 8053929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiviral activity of 2-acetylpyridine thiosemicarbazones against herpes simplex virus.
    Shipman C; Smith SH; Drach JC; Klayman DL
    Antimicrob Agents Chemother; 1981 Apr; 19(4):682-5. PubMed ID: 6264853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The potent and novel thiosemicarbazone chelators di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone and 2-benzoylpyridine-4,4-dimethyl-3-thiosemicarbazone affect crucial thiol systems required for ribonucleotide reductase activity.
    Yu Y; Suryo Rahmanto Y; Hawkins CL; Richardson DR
    Mol Pharmacol; 2011 Jun; 79(6):921-31. PubMed ID: 21389104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptidomimetic inhibitors of herpes simplex virus ribonucleotide reductase with improved in vivo antiviral activity.
    Moss N; Beaulieu P; Duceppe JS; Ferland JM; Garneau M; Gauthier J; Ghiro E; Goulet S; Guse I; Jaramillo J; Llinas-Brunet M; Malenfant E; Plante R; Poirier M; Soucy F; Wernic D; Yoakim C; Déziel R
    J Med Chem; 1996 Oct; 39(21):4173-80. PubMed ID: 8863795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.